Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer.
Epidemiologic studies indicate that elevated levels of gamma-glutamyltransferase (GGT), a key enzyme of glutathione metabolism, might be associated with increased cancer risk. Furthermore, preclinical studies support a role for GGT in tumor invasion and progression. However, the relationship between GGT and risks of cervical intraepithelial neoplasia III (CIN-III) and invasive cervical cancer (ICC) have not been evaluated. We investigated the association of enzymatically determined GGT in blood serum with subsequent incidence of CIN-III and ICC in a prospective population-based cohort of 92,843 women ages 18 to 95, of whom 79% had at least one gynecologic examination including Pap smear testing during follow-up. Cox regression was used to compute adjusted hazard ratios (HR) with 95% confidence intervals for the association of GGT with CIN-III and ICC. During median follow-up of 13.8 years, 702 CIN-III and 117 ICC diagnoses were observed. Compared with normal low GGT (<17.99 units/L), risk of ICC was significantly elevated for all other baseline GGT categories, with adjusted HRs of 2.31 (1.49-3.59) for normal high GGT (18.00-35.99 units/L), 2.76 (1.52-5.02) for elevated GGT (36.00-71.99 units/L), and 3.38 (1.63-7.00) for highly elevated GGT [>72.00 units/L; P trend < 0.0001, HR log unit increase 3.45 (1.92-6.19)]. In contrast, associations between GGT serum levels and CIN-III risk were not statistically significant in the main analysis. Exclusion of the first 2 or 5 years of follow-up did not change the results. Effects did not differ by age, body mass index, or socioeconomic status. Our findings implicate GGT in the progression of premalignant cervical lesions to invasive cancer.
Strasak
Alexander M
AM
Departments of Medical Statistics, Innsbruck Medical University, Innsbruck, Austria.
Goebel
Georg
G
Concin
Hans
H
Pfeiffer
Ruth M
RM
Brant
Larry J
LJ
Nagel
Gabriele
G
Oberaigner
Willi
W
Concin
Nicole
N
Diem
Günter
G
Ruttmann
Elfriede
E
Gruber-Moesenbacher
Ulrike
U
Offner
Felix
F
Pompella
Alfonso
A
Pfeiffer
Karl P
KP
Ulmer
Hanno
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001317:Austria / Q000453:epidemiology; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011446:Prospective Studies; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000201:enzymology* / Q000453:epidemiology / Q000473:pathology; D055815:Young Adult; D005723:gamma-Glutamyltransferase / Q000097:blood*; D002578:Uterine Cervical Dysplasia / Q000201:enzymology* / Q000453:epidemiology / Q000473:pathology
D005723:gamma-Glutamyltransferase
Int J Gynecol Pathol. 1993 Apr;12(2):186-92
8463044
Acta Cytol. 2009 Jan-Feb;53(1):10-7
19248549
Free Radic Biol Med. 1999 Sep;27(5-6):623-35
10490284
Lancet. 2007 Sep 8;370(9590):890-907
17826171
Curr Opin Pharmacol. 2007 Aug;7(4):360-6
17613273
Ann Intern Med. 1984 Dec;101(6):847-51
6149716
Obstet Gynecol. 2008 Jan;111(1):167-77
18165406
Int J Cancer. 2009 Jan 1;124(1):188-93
18785204
Environ Health Perspect. 2006 Mar;114(3):350-4
16507456
Virology. 2009 Feb 20;384(2):260-5
19135222
Clin Chem. 2006 Sep;52(9):1825-7
16940464
Diagn Cytopathol. 2009 Jun;37(6):411-5
19191295
Clin Chim Acta. 1972 Jun;39(1):75-80
5038765
Eur Heart J. 2003 Jun;24(11):1004-13
12788300
Eur J Cancer. 2006 Oct;42(15):2623-30
16928443
Biochem Pharmacol. 2006 Jan 12;71(3):231-8
16303117
CA Cancer J Clin. 1998 Jan-Feb;48(1):6-29
9449931
Crit Rev Clin Lab Sci. 2001 Aug;38(4):263-355
11563810
Semin Surg Oncol. 1999 Apr-May;16(3):203-11
10225296
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):113-20
19124488
Int J Cancer. 2008 Oct 15;123(8):1902-6
18688855
Gastroenterology. 2009 Feb;136(2):477-85.e11
19100265
Carcinogenesis. 1999 Apr;20(4):553-9
10223181
Carcinogenesis. 1985 Feb;6(2):165-72
2857599
Cancer Res. 2008 May 15;68(10):3970-7
18483283